![Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial | Nature Medicine Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial | Nature Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-02026-4/MediaObjects/41591_2022_2026_Fig2_HTML.png)
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial | Nature Medicine
![BWeL: Brief intervention on weight loss trial — Nuffield Department of Primary Care Health Sciences, University of Oxford BWeL: Brief intervention on weight loss trial — Nuffield Department of Primary Care Health Sciences, University of Oxford](https://www.phc.ox.ac.uk/images/news-1/anon/@@images/20548258-5803-496f-ade4-79406bbb1fda.png)
BWeL: Brief intervention on weight loss trial — Nuffield Department of Primary Care Health Sciences, University of Oxford
![Accessing Wegovy for weight loss: Everything you need to know – Department of Health and Social Care Media Centre Accessing Wegovy for weight loss: Everything you need to know – Department of Health and Social Care Media Centre](https://healthmedia.blog.gov.uk/wp-content/uploads/sites/169/2023/09/Design-1.png)
Accessing Wegovy for weight loss: Everything you need to know – Department of Health and Social Care Media Centre
![Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data | International Journal of Obesity Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data | International Journal of Obesity](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41366-020-00733-x/MediaObjects/41366_2020_733_Fig1_HTML.png)
Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data | International Journal of Obesity
![Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme | Diabetologia Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme | Diabetologia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-020-05224-2/MediaObjects/125_2020_5224_Figa_HTML.png)